Works matching IS 10584838 AND DT 2012 AND VI 55 AND IP suppl_2
Results: 16
Current Status of Clostridium difficile Infection Epidemiology.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S65, doi. 10.1093/cid/cis319
- By:
- Publication type:
- Article
Current State of Clostridium difficile Treatment Options.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S71, doi. 10.1093/cid/cis355
- By:
- Publication type:
- Article
Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S104, doi. 10.1093/cid/cis357
- By:
- Publication type:
- Article
Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S132, doi. 10.1093/cid/cis338
- By:
- Publication type:
- Article
Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficile Infections.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S110, doi. 10.1093/cid/cis390
- By:
- Publication type:
- Article
Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S127, doi. 10.1093/cid/cis358
- By:
- Publication type:
- Article
Fidaxomicin Inhibits Spore Production in Clostridium difficile.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S162, doi. 10.1093/cid/cis453
- By:
- Publication type:
- Article
Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S149, doi. 10.1093/cid/cis340
- By:
- Publication type:
- Article
Burden of Clostridium difficile on the Healthcare System.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S88, doi. 10.1093/cid/cis335
- By:
- Publication type:
- Article
Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S121, doi. 10.1093/cid/cis440
- By:
- Publication type:
- Article
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S77
- By:
- Publication type:
- Article
Antimicrobial Activities of Fidaxomicin.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S143, doi. 10.1093/cid/cis339
- By:
- Publication type:
- Article
Fidaxomicin Attains High Fecal Concentrations With Minimal Plasma Concentrations Following Oral Administration in Patients With Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S116, doi. 10.1093/cid/cis337
- By:
- Publication type:
- Article
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S154, doi. 10.1093/cid/cis462
- By:
- Publication type:
- Article
Clinical Infectious Diseases.
- Published in:
- 2012
- Publication type:
- Film/TV Criticism and Review
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. suppl_2, p. S93, doi. 10.1093/cid/cis499
- By:
- Publication type:
- Article